1. A step backwards in the fight against global vaccine inequities.;Aryeetey;Lancet,2021
2. Emerging technologies for low-cost, rapid vaccine manufacture.;Kis;Biotechnol J,2019
3. World Health Organization. ACT-Accelerator: an economic investment case & financing requirements, September 2020-December 2021. Published September 25, 2020. Accessed February 3, 2021. https://www.who.int/docs/default-source/coronaviruse/act-accelerator/economic-investment-case-final-v2.pdf
4. World Health Organization. Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21, and US$ 466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group. December 3, 2020. Accessed February 3, 2021. https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21
5. India’s statement delivered by ambassador & PR to the WTO at the general council meeting held on 18 December, 2020 on agenda item No. 13B—status report on the consideration by the TRIPS Council of the ‘Proposal for Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19’—statement by the chair of the Council for TRIPS. Accessed February 3, 2021. https://pmindiaun.gov.in/statements/MjM2Mg